6
Oct
2026
Srs Life Sciences Pte. Ltd.
Exhibitor at CPHI Milan 2026 stand 14B26, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Singapore
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 14B26, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Ademetionine Tablets
Meets the RLD Heptral -
Product Canagliflozin Tablets
Meets the RLD EU, US InvoKana -
Product Cariprazine Capsules
Under development, The RLD used is Vraylar -
Product Deferasirox Sprinkle Oral Granules
Deferasirox Sprinkle granules were developed to improve palatability and patient adherence.
and it is in compliance to EU RLD Jadenu -
Product Azithromycin Powder for oral solution 200 mg/5ml
RLD used is Zithromax (Pfizer). Product is been developed for Emerging nations.
Srs Life Sciences Pte. Ltd. Resources (1)
-
Video SRS Life Sciences Pte Ltd at CPHI Worldwide 2018
Rajah Dubey, Chief Technical Strategist of SRS Life Sciences, speaks with CPHI TV at CPHI Worldwide in Madrid.
